← Back
$KYTX All transactions

Kyverna Therapeutics, Inc.

A

$ Value

$0

Shares

65,351

Price

$0

Filed

Jun 2

Insider

Name

Cohen Fred E

Title

CIK

0001339358

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-05-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

65,351

Footnotes

Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. | All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. | Shares held directly by Vida Ventures, LLC ("Vida"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any.

Filing Info

Accession No.

0000950170-25-080447

Form Type

4

Issuer CIK

0001994702

Cohen Fred E's History

Date Ticker Type Value
2026-01-05 NTLA $1.4M
2025-06-13 CDNA A $0
2025-06-11 NTLA A $0
2025-06-11 NTLA A $0
2025-05-29 KYTX A $0
2025-05-29 KYTX A $0

Other Insiders at KYTX (90d)

Insider Bought Sold Last
GRASSO MARC
Chief Financial Officer
2026-03-13
Miller Andrew Craig 2026-02-24
Emany Sravan Kumar 2026-02-24
Biddle Warner Weston
Chief Executive Officer
2026-03-13
GEHCHAN NAJI
See Remarks
2026-03-13
Pujols Mayobanex
Chief Technology Officer
2026-02-09